Natera (NTRA) News Today

Natera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 690 shares of Natera stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $105.29, for a total transaction of $72,650.10. Following the transaction, the chief financial officer now owns 75,810 shares in the company, valued at approximately $7,982,034.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Natixis bought a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,283 shares of the medical research company's stock, valued at approximately $758,000. Several other large investors al

Natera (NASDAQ:NTRA) Sees Large Volume Increase

Vanguard Group Inc. lifted its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 0.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,044,743 shares of the medical resea

Russell Investments Group Ltd. increased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 15.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,460 shares of the med

Natera, Inc. (NASDAQ:NTRA - Free Report) - Leerink Partnrs dropped their Q2 2024 earnings estimates for shares of Natera in a report released on Thursday, July 18th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings of ($0.59) per share for the

M&G Plc acquired a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 90,101 shares of the medical research company's stock, value

Natera (NASDAQ:NTRA) Trading 3.2% Higher

Natera (NASDAQ:NTRA) Stock Price Down 7% on Insider Selling

Entropy Technologies LP acquired a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 8,617 shares of the medical research compa

Sei Investments Co. grew its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 4.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 368,942 shares of the medical research company's stock after pu

Lisanti Capital Growth LLC acquired a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 13,005 shares of the medical research company's stock, valued at approximately $1,189,000. Other hed

Zevenbergen Capital Investments LLC grew its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 11.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 487,631 shares of the medi

Chevy Chase Trust Holdings LLC purchased a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 158,183 shares of the medical

BNP Paribas Financial Markets cut its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 4.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 175,297 shares of the medical research company's stock after selling 8,078

Jennison Associates LLC increased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 121.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 472,147 shares of the medical research company's st

Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 257.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 307,716 shares of the medical research company's stock a

Natera, Inc. (NASDAQ:NTRA - Get Free Report) has been assigned a consensus recommendation of "Buy" from the sixteen ratings firms that are covering the stock, Marketbeat Ratings reports. Sixteen analysts have rated the stock with a buy recommendation. The average 12-month price target among broker

Van ECK Associates Corp increased its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 14.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 112,499 shares of the medical research company's stock after acquiring an additional 13,898 shares durin

Natera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 4,983 shares of the stock in a transaction on Monday, July 1st. The stock was sold at an average price of $108.37, for a total value of $540,007.71. Following the completion of the transaction, the chief financial officer now owns 75,059 shares of the company's stock, valued at approximately $8,134,143.83. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Allspring Global Investments Holdings LLC lifted its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 19.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 863,406 shares of the medical research company's sto

Artemis Investment Management LLP lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 40.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 234,096 shares of the medical research com

Vanguard Group Inc. grew its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,971,895 shares of the medical research company's stock after pur

Goldman Sachs Group Inc. trimmed its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 77.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 812,941 shares of the medical research co

Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 674.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,000 shares of the medical

Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including

Perceptive Advisors LLC raised its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 289.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 850,225 shares of the medical

Osterweis Capital Management Inc. raised its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 9.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 87,850 shares of the medical research company's stock afte

Prelude Capital Management LLC cut its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 19.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 68,567 shares of the medical research company's stock after selling 16,121

First Light Asset Management LLC bought a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 165,886 shares of the medical research company's stock, valued at approxima

Natera (NASDAQ:NTRA) Hits New 12-Month High at $117.07

Avidity Partners Management LP raised its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 23.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,110,000 shares of the medical research company's stock after buying an

Kynam Capital Management LP reduced its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 20.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,400,000 shares of the medical research company

RTW Investments LP decreased its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 2.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,593,323 shares of the medical research company's stock after selling 58,460 shares du

Natera (NASDAQ:NTRA) Reaches New 1-Year High at $110.92